1. Dasatinib (Sprycel™) Medical Review, FDA 21-986 & 22-072, June 2006.
2. Dasatinib (Sprycel™) Pharmacology Review, FDA 21-986 & 22-072, June 2006.
3. Dasatinib (Sprycel™) Medical Review, FDA 21-986/S001 & 002, November 2007.
4. Sprycel® (dasatinib) Prescribing information, BMS, August 2015.
5. Dasatinib (Sprycel®) Scientific Discussion, EMEA WC500056995, November 2006.